Physician profile
Rojin Abdullah
NPI 1982292447
$1,909.42
in general payments reported to CMS, 2019-2025
19 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.28 · 2022: $344 · 2023: $842 · 2024: $153 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $654.12 | 2024-2025 | Stravix, Grafix Pl, Grafix |
| Lilly USA, LLC | $302.14 | 2022-2023 | Mounjaro, Jardiance, Lyumjev |
| Novo Nordisk INC | $114.56 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $113.28 | 2022-2025 | Evenity, Prolia |
| Abbvie INC. | $110.07 | 2022-2023 | Synthroid |
| Sanofi-Aventis U.S. LLC | $101.86 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.17 | 2022-2023 | Synjardy, Jardiance |
| Xeris Pharmaceuticals, INC. | $69.85 | 2022-2023 | Gvoke Hypopen |
| Insulet Corporation | $68.15 | 2022-2023 | Omnipod |
| Dexcom, INC. | $51.22 | 2022-2023 | Dexcom G6 Transmitter |
| Cequr Corporation | $46.53 | 2023 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals Lp | $42.50 | 2022-2023 | Farxiga |
| Pfizer INC. | $39.28 | 2021 | |
| Antares Pharma, INC. | $19.99 | 2023 | Nocdurna, Xyosted, Tlando |
| Exeltis, USA INC. | $17.70 | 2023 | Slynd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $16.96 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.68 | 2024 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $14.54 | 2022 | |
| Corcept Therapeutics | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rojin Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.